PL321239A1 - Mutations of proteins - Google Patents

Mutations of proteins

Info

Publication number
PL321239A1
PL321239A1 PL96321239A PL32123996A PL321239A1 PL 321239 A1 PL321239 A1 PL 321239A1 PL 96321239 A PL96321239 A PL 96321239A PL 32123996 A PL32123996 A PL 32123996A PL 321239 A1 PL321239 A1 PL 321239A1
Authority
PL
Poland
Prior art keywords
mutations
proteins
Prior art date
Application number
PL96321239A
Other languages
English (en)
Inventor
Joachim Hauber
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9502771.0A external-priority patent/GB9502771D0/en
Priority claimed from GBGB9513505.9A external-priority patent/GB9513505D0/en
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of PL321239A1 publication Critical patent/PL321239A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL96321239A 1995-02-13 1996-02-12 Mutations of proteins PL321239A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9502771.0A GB9502771D0 (en) 1995-02-13 1995-02-13 Organic compounds
GBGB9513505.9A GB9513505D0 (en) 1995-07-03 1995-07-03 Organic compounds

Publications (1)

Publication Number Publication Date
PL321239A1 true PL321239A1 (en) 1997-11-24

Family

ID=26306494

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96321239A PL321239A1 (en) 1995-02-13 1996-02-12 Mutations of proteins

Country Status (15)

Country Link
EP (1) EP0811060A1 (fi)
JP (1) JPH10509327A (fi)
KR (1) KR19980702160A (fi)
CN (1) CN1173897A (fi)
AU (1) AU4665196A (fi)
BR (1) BR9606951A (fi)
CA (1) CA2210538A1 (fi)
CZ (1) CZ255397A3 (fi)
FI (1) FI972763A (fi)
HU (1) HUP9801681A3 (fi)
IL (1) IL117113A0 (fi)
NO (1) NO973679L (fi)
PL (1) PL321239A1 (fi)
SK (1) SK109997A3 (fi)
WO (1) WO1996025492A1 (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1002079A2 (en) * 1997-06-30 2000-05-24 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Novel inhibitor of cellular proliferation
US7968523B2 (en) * 2001-07-23 2011-06-28 Senesco Technologies, Inc. Method for inducing apoptosis using apoptosis-specific EIF5-A
US7381708B2 (en) 2001-07-23 2008-06-03 Sensco Technologies, Inc. Suppression of eIF5A1 expression by the use of antisense oligonucleotides for the prevention of retinal cell death in the glaucomatous eye
US7217517B2 (en) * 2001-07-23 2007-05-15 Senesco Technologies, Inc. Nucleic acids, polypeptides, and methods for modulating apoptosis
US7166467B2 (en) * 2001-07-23 2007-01-23 Senesco Technologies, Inc. Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis
US6867237B1 (en) * 2001-07-23 2005-03-15 Senesco Technologies, Inc. DNA encoding apoptosis-induced eucaryotic initiation factor-5A and deoxyhypusine synthase and a method for controlling apoptosis in animals and humans
EP1601767B1 (en) 2003-03-05 2012-04-25 Senesco Technologies, Inc. USE OF siRNA TO SUPPRESS EXPRESSION OF EIF-5A1 IN THE TREATMENT OF GLAUCOMA
AU2004258070B2 (en) * 2003-06-06 2008-12-11 Senesco Technologies, Inc. Inhibition of apoptosis-specific elF-5A ("elF-5A1") with antisense oligonucleotides and siRNAs as anti-inflammatory therapeutics
CN102282259A (zh) 2008-03-07 2011-12-14 森尼斯科技术公司 与有义构建体实现期望多核苷酸的表达的用途相组合的、sirna实现内源基因的减量调节的用途
US8445638B2 (en) 2008-09-03 2013-05-21 Senesco Technologies, Inc. Use of a truncated eIF-5A1 polynucleotide to induce apoptosis in cancer cells

Also Published As

Publication number Publication date
MX9705757A (es) 1998-07-31
SK109997A3 (en) 1998-04-08
CA2210538A1 (en) 1996-08-22
JPH10509327A (ja) 1998-09-14
NO973679L (no) 1997-10-13
HUP9801681A3 (en) 2000-10-30
BR9606951A (pt) 1997-10-28
WO1996025492A1 (en) 1996-08-22
AU4665196A (en) 1996-09-04
IL117113A0 (en) 1996-06-18
NO973679D0 (no) 1997-08-11
EP0811060A1 (en) 1997-12-10
FI972763A0 (fi) 1997-06-26
FI972763A (fi) 1997-10-10
HUP9801681A2 (hu) 1998-10-28
CZ255397A3 (cs) 1998-02-18
CN1173897A (zh) 1998-02-18
KR19980702160A (ko) 1998-07-15

Similar Documents

Publication Publication Date Title
HUP9900422A3 (en) Novel protein and methods for the production of the same
AU5893696A (en) Modification of polypeptides
GB9526560D0 (en) Use of 2-Amino-Heterocycles
AU5893796A (en) Modification of polypeptides
IL116924A0 (en) Preparation of n-aryl- and n-hetarylhydroxylamines
GB9510830D0 (en) Proteins
PL321239A1 (en) Mutations of proteins
SG42329A1 (en) Use of phenylcyclohexylcarboxamides
HUP9801330A3 (en) Novel pka-binding proteins and uses thereof
IL115317A0 (en) Proteins
AU5284296A (en) Immune-evading proteins
GB9519865D0 (en) Protein
IL117786A (en) Preparation of alpha-bisoximes
NZ307236A (en) Preparation of streptogramins
AU6153396A (en) E6ap-binding proteins
GB9622436D0 (en) Protein
GB9513043D0 (en) Selection of recombinant molecules
GB9509102D0 (en) Modified proteins
GB9524341D0 (en) Proteins
GB9502138D0 (en) Proteins
IL118225A0 (en) Use of felodipine
ZA955497B (en) Peptide derivatives of alpha-MSH-and their application
GB9501486D0 (en) Protein
GB9511729D0 (en) Protein
GB9522660D0 (en) Protein